Better control of antibiotic resistance

Clinical Infectious Diseases

Volumn 33, Issue 4, 2001, Pages 542-547

  Guillemot, D ^a   Courvalin, P ^b  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; DRUG USE; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; RESEARCH;

EID: 0035882186     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/322583     Document Type: Review

References (57)

1. Antibiotic resistance in Spain: What can be done?
2. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
3. Resistant pneumococci: Protecting patients through judicious use of antibiotics
4. Outpatient use of erythromycin: Link to increased erythromycin resistance in group A streptococci
5. Low dosage and long treatment duration of β-lactam: Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae
6. Bacterial resistance in acne
7. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada
8. Can susceptibility to an antimicrobial be restored by halting its use? The case of streptomycin versus Enterobacteriaceae
9. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients
10. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases
11. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
12. Resistance to antibiotics used in dermatological practice
13. Antibiotic resistance: What can we do?
14. Superbugs: Should antimicrobial resistance be included as a cost in economic evaluation?
15. Health and economic impacts of antimicrobial resistance
16. Understanding the culture of prescribing: Qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats
17. Reducing antibiotics for respiratory tract symptoms in primary care: Consolidating "why" and considering "how"
18. The influence of antibiotics and other factors on reconsultation for acute lower respiratory tract illness in primary care
19. Parents' and physicians' views on antibiotics
20. Parents, physicians, and antibiotic use
21. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior
22. Antibiotic-selective environments
23. Gene transfer between distantly related bacteria
24. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis
25. Child-care practices: Effects of social change on the epidemiology of infectious diseases and antibiotic resistance
26. Antibiotic-selective environments
27. The public and domestic domains in the transmission of disease
28. Reducing antibiotic resistance
29. Virulence of antibiotic-resistant Salmonella typhimurium
30. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
31. Conjugal transfer of plasmid DNA from Enterococcus faecalis to Escherichia coli in digestive tracts of gnotobiotic mice
32. Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice
33. R-plasmid transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora
34. Resistance to antimicrobial chemotherapy: A prescription for research and action
35. The population genetics of antibiotic resistance
36. Evaluating treatment protocols to prevent antibiotic resistance
37. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
38. The transmission dynamics of antibiotic-resistant bacteria: The relationship between resistance in commensal organisms and antibiotic consumption
39. Multidrug resistance in enteric and other gram-negative bacteria
40. Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli
41. High mutation frequencies among Escherichia coli and Salmonella pathogens
42. To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly
43. Highly variable mutation rates in commensal and pathogenic Escherichia coli
44. Genetic barriers among bacteria
45. Rate of plasmid transfer among Escherichia coli strains isolated from natural populations
46. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: The case for judicious antimicrobial use
47. Antibiotic use and pneumococcal resistance to penicillin: "The French experience"
48. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998
49. Susceptibility testing instrumentation and computerized expert systems for data analysis and interpretation
50. Molecular basis of vaccination
51. Inhibition of virulence factors in bacteria
52. New targets and strategies for the development of antibacterial agents
53. Probiotics and prebiotics microflora management of improved gut health
54. Epidemiology of drug resistance: Implications for a post-antimicrobial era
55. The crisis in antibiotic resistance
56. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
57. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin